Oklahoma Clinical Trials
Browse actively recruiting clinical trials with research sites in Oklahoma. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Oklahoma
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296Ganglioneuroblastoma, NodularOklahoma City, OK
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsNCT04657068Advanced CancerOklahoma City, OK
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967Anatomic Stage IV Breast Cancer AJCC v8Oklahoma City, OK
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersNCT07221851Turner SyndromeOklahoma City, OK
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019Secondary Progressive Multiple SclerosisOklahoma City, OK
- Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsNCT06706674Irritability Associated With Autism Spectrum DisorderOklahoma City, OK
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyNCT06541704Age-related Macular Degeneration (AMD)Edmond, OK
- Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaNCT05112601Endometrial AdenocarcinomaOklahoma City, OK
- A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781Low Grade Serous Ovarian CancerOklahoma City, OK
- Chemotherapy With or Without Immunotherapy for Peritoneal MesotheliomaNCT05001880Peritoneal Malignant MesotheliomaOklahoma City, OK
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaNCT04166409Low Grade AstrocytomaOklahoma City, OK
- Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT TrialNCT07061964Muscle Invasive Bladder Urothelial CarcinomaOklahoma City, OK
Clinical trials by Oklahoma metro
Popular conditions in Oklahoma
Frequently asked questions
- How do I find clinical trials in Oklahoma?
- Corterve aggregates actively recruiting clinical trials with sites in Oklahoma from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.
- Are clinical trials in Oklahoma free to join?
- Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.
- What kinds of clinical trials are available in Oklahoma?
- Oklahoma research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.